Jazz Pharmaceuticals to Participate in Upcoming March Investor Conferences

Rhea-AI Summary

On February 27, 2023, Jazz Pharmaceuticals (Nasdaq: JAZZ) announced its participation in two upcoming investor conferences. The first is the Cowen 43rd Annual Health Care Conference on March 7, 2023, in Boston, where management will participate in a fireside chat at 12:50 p.m. ET. The second is the J.P. Morgan 12th Annual Napa Valley Biotech Forum on March 21, 2023, in San Francisco, with a fireside chat at 1:45 p.m. ET. A live audio webcast of these events will be available on the Jazz Pharmaceuticals website, along with a replay for 30 days post-event.

DUBLIN, Feb. 27, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the following upcoming investor conferences:

Cowen 43rd Annual Health Care Conference

• Date: Tuesday, March 7, 2023
• Location: Boston
• Company management will participate in a fireside chat at 12:50 p.m. ET / 5:50 p.m. GMT
• A live audio webcast may be accessed via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. A replay of the webcast will be available on the website for 30 days following the conference.

J.P. Morgan 12^th Annual Napa Valley Biotech Forum

• Date: Tuesday, March 21, 2023
• Location: San Francisco
• Company management will participate in a fireside chat at 1:45 p.m. ET / 6:45 p.m. GMT

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. Please visit www.jazzpharmaceuticals.com for more information.

Contacts:

Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Ireland +353 1 634 3211
U.S. +1 650 496 2717

Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948

View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-march-investor-conferences-301755785.html

SOURCE Jazz Pharmaceuticals plc

FAQ

When is Jazz Pharmaceuticals participating in the Cowen Health Care Conference?

Jazz Pharmaceuticals will participate in the Cowen 43rd Annual Health Care Conference on March 7, 2023.

Where will Jazz Pharmaceuticals' management participate in a fireside chat?

Management will participate in a fireside chat in Boston during the Cowen Health Care Conference.

What time is the fireside chat by Jazz Pharmaceuticals on March 7, 2023?

The fireside chat will take place at 12:50 p.m. ET on March 7, 2023.

When is the J.P. Morgan Napa Valley Biotech Forum?

The J.P. Morgan 12th Annual Napa Valley Biotech Forum will be held on March 21, 2023.

What time is Jazz Pharmaceuticals' fireside chat at the Napa Valley Biotech Forum?

The fireside chat will occur at 1:45 p.m. ET on March 21, 2023.